AzTrials
AzTrials

Postpartum ComplicationNCT06303232

Effects of Manual Lymphatic Drainage and Therapeutic Ultrasound on Breast Engorgement

A study testing MANUAL LYMPHATIC DRAINAGE and THERAPEUTIC ULTRASOUND in people with Postpartum Complication, run by Riphah International University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To find the combined effects of the manual lymphatic drainage with therapeutic ultrasound on breast engorgement, pain and self-efficacy in post - partum women. Read more about this study

Who is it for?
Ages 18 to 35 years, women only
Conditions the study is for
Postpartum Complication
What is being tested?
MANUAL LYMPHATIC DRAINAGE and THERAPEUTIC ULTRASOUND
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 sitePakistan
Study dates
23 Feb 2023to 19 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Both primiparous or multiparous breastfeeding women
  • BMI: ≤30-≥25 (14)
  • Immediate puerperium with normal or C - section non-premature childbirth (19)
  • Postnatal lactating mother with symptoms of breast engorgement

Who cannot join

  • any breast infection, abscess, mastitis, breast cancer
  • torn/bleeding or crack nipples
  • any skin condition like dermatitis, psoriasis etc
  • non-lactating mothers
  • having heart pacemaker

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Innovative Health Concepts Clinic

    Lahore, 05499

Other trials in Pakistan

About this study

Official title: Combined Effects of Manual Lymphatic Drainage and Therapeutic Ultrasound on Breast Engorgement, Pain and Self Efficacy in Postpartum Women

To find the combined effects of the manual lymphatic drainage with therapeutic ultrasound on breast engorgement, pain and self-efficacy in post - partum women.

Being tested
MANUAL LYMPHATIC DRAINAGE, THERAPEUTIC ULTRASOUND
Keywords
Breast engorgement, manual lymphatic drainage, therapeutic ultrasound, pain, self-efficacy, post - partum women.
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MANUAL LYMPHATIC DRAINAGEOther

    MLD was performed after the moist heating of 10 minutes in supine position with both knees bent. It will start from the abdominal lymph drainage followed by the central lymph drainage.

    Then, by stimulating the bilateral axillary lymph nodes, the flow of the fluid was directed to the axillary lymph node. Each session lasted for approximately 45 minutes, for 7 days

  • THERAPEUTIC ULTRASOUNDOther

    The participants of group B will receive a treatment of manual lymphatic drainage and ultrasound after the moist heat of 10 minutes. After MLD of 45 minutes, ultrasound will be performed in small circular pattern from periphery to the center towards the areola with following parameters: Mode: pulsed, Frequency: 1MHz, Intensity: 1W/cm2, Time: 8 minutes. Treatment was given for 7 consecutive days

Study groups in NCT06303232
Study groupRoleWhat they receive
MANUAL LYMPHATIC DRAINAGEExperimentalNot described
Receives: Other: MANUAL LYMPHATIC DRAINAGE
THERAPEUTIC ULTRASOUNDActive comparatorNot described
Receives: Other: THERAPEUTIC ULTRASOUND

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale - VAS

    VAS is an effective rule is measuring the pain score. It ranges from 0 -10 cm line scale with the following description; 0 cm = no pain

    1 - 3 cm = mild pain 4 - 7 cm = moderate pain 8 - 10 cm = severe pain (20). When assessing the validity of VAS, a good-to-excellent correlation was found (r = 0.941), this scale had excellent test-retest reliability. The intra - class correlation coefficients of the VAS was 0.97

    Measured: 7th day

  2. Six Point Engorgement Scale - SPE

    Six point engorgement scale was the scale for the determination of the breast engorgement.

    The reliability of tool engorgement was 0.948 (22). The score of this scale ranges from 1 - 6.

    Every score has a following description;

    1. = no changes in breast / soft breast
    2. = slight changes in breast
    3. = firm but no breast tenderness
    4. = firm with starting breast tenderness
    5. = tender and firm
    6. = very tender and very firm

    Measured: 7th day

  3. Breastfeeding Self-Efficacy Scale - BSES

    It includes the 14 items that measure the confidence of the breastfeeding. The divergent validity of the BSES-SF was proved via a significant negative correlation with scores of the Edinburgh Postnatal Depression Scale (r = - 0.273, P < 0.001). In sum, BSES-SF is a reliable and valid instrument for measuring breastfeeding self-efficacy

    Measured: 7th day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2024
  2. Study start23 Feb 2023
  3. Primary completion1 Aug 2024
  4. Study completion19 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06303232
Sponsor's protocol ID
REC/RCR&AHS/23/0578
Status last verified
Sep 2024
First submitted
4 Mar 2024
Last updated
4 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lyons KE, Ryan CA, Dempsey EM, Ross RP, Stanton C. Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health. Nutrients. 2020 Apr 9;12(4):1039. doi: 10.3390/nu12041039.

    PubMed 32283875
  • Mitchell KB, Johnson HM. Breast conditions in the breastfeeding mother. Breastfeeding: Elsevier; 2022. p. 572-93.

  • Napisah P, Widiasih R, Maryati I, Hermayanti Y, Natasya W. The effectiveness of cabbage leaf compress and the education of lactation management in reducing breast engorgement in postpartum. Open Access Macedonian Journal of Medical Sciences. 2021;9(T6):106-10.

  • Indrani D, Sowmya M. A study to find the prevalence of breast engorgement among lactating Mothers. J Reprod Med Gynecol Obstet. 2019;4:023

  • Aprilina HD, Krislinggardini K, Isnaini N, Suratmi S. The effect of cabbage leaves compress on breast engorgement in postpartum mother. Open Access Macedonian Journal of Medical Sciences. 2021;9(T4):124-8

  • Zutshi K, Aman I, Sachdeva T, Khatoon R. Physiotherapy Approach to Breast Engorgement: A Systematic Review. International Journal of Advanced Research in Gynaecology and Obstetrics. 2023;1(1):34-8.

  • Varghese B, Patwa A. Effectiveness of hospital based teaching programme on knowledge regarding home management for breast engorgement among postnatal mothers. Int J Res Rev. 2020;7:486-93.

Questions about this trial

What is this clinical trial studying?

A study testing MANUAL LYMPHATIC DRAINAGE and THERAPEUTIC ULTRASOUND in people with Postpartum Complication, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale - VAS (time frame: 7th day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06303232, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in